Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-397-7 | CAS number: 847488-62-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Expert statement: C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate has a minor potential for bioaccumulation. The relevant absorption rates can be estimated by expert judgement to 50% (oral, including metabolites and hydrolysis products), 50% (dermal) and 25% (inhalation).
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 25
Additional information
In order to assess the toxicokinetic behaviour of C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, the available toxicological and physico-chemical data were evaluated.
The substance, i.e. the unchanged parent compound, is expected to be rather poorly absorbed via the oral route. With a molecular weight of 460.7 g/mol, absorption in general can be considered as possible. However, taking into account the Log Pow of Log Pow = 3.56 (at 25°C), might indicate a beginning slightly hindered absorption e.g. by diffusion, and also, only water-soluble substances will readily dissolve into the gastrointestinal fluids and hence be available for absorption, which limits the absorption of the poorly soluble compound. The presence of absorption is indicated by some effects observed in animal studies.
Based on the chemical structure of the substance, a hydrolysis of the parent compounds needs to be taken into account, which are most likely 3,5-Di-tert-butyl-4-hydroxyphenylpropionic acid and isotridecanol.In general, the low molecular weight of the hydrolysis products makes them favourable for absorption. The uptake of the long-chain alcohols seems to be limited due to their low water solubility and high Log Pow and is also not toxicologically relevant due to their non-toxicity. Similar considerations with regard to absorption apply to 3,5-Di-tert-butyl-4-hydroxyphenylpropionic acid, however, without information on the toxicological relevance.
It is also unknown to which extent the absorption of the hydrolysis products needs to be regarded. As the oral absorption of the parent compound can be considered as limited, the oral absorption rate can be estimated to approx. 25%. Since hydrolysis is nevertheless a very likely scenario, the degradation products and their uptake should be considered, too. This leads to the estimation of a precautionary absorption rate of approx. 50% due to the similarly hindered absorption as the parent compound, probably overestimating the actual oral absorption.
C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate (data from EC 413-750-2) has a rather low vapour pressure (e.g. 166 Pa at 20°C, 430 Pa at 40°C) and a boiling point of 220-245°C at 101.3 kPa, showing that the inhalative absorption as a gas does not have to be regarded, which is supported by the fact that it is liquid at room temperature, i.e. no particles of an inhalable size are present. Thinking of a possible, but very unlikely inhalation of an aerosol and considering the available phys.-chem. data, the absorption of the parent compound as well as possible hydrolysis products can be neglected and since the concretehydrolysis rate is not available, a precautionary absorption rate of up to 25% can be estimated.
In case of C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, neither evaporation after skin contact nor very remarkable additional absorption-enhancing effects due to corrosivity need to be regarded. Taking into account the molecular weight, high Log Pow and low water solubility, a passage of the parent compound and similarly the possible hydrolysis products through the stratum corneum is unlikely, but cannot be completely excluded. Due to uncertainty issues, a precautionary absorption rate of 50% should be taken into account.
Taking into account the molecular weight of 460.7 g/mol, the rather lipophilic character and poor water solubility, the absolute systemic bioavailability is rather low and expected to be more extensive in fat tissues than in other tissues. Similar considerations apply to the potential hydrolysis products, although their bioavailability, if occurring, might be slightly enhanced compared to the parent compound. As, after first pass metabolism, more hydrophilic metabolites are expected to occur, and a rather minor absorption of C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate, no relevant peak exposure, AUC and prolonged bioavailability will occur.
Since C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate is not considered especially hydrolytically or metabolically stable, a prolonged, extensive accumulation is not expected. After metabolism, the excretion of the metabolites, either as such or after Phase 2 metabolism, will occur rather fast, as well as the unchanged hydrolysis products and their metabolites would, an accumulation is not very likely, too. The sites of metabolism of the parent compound as well as hydrolysis products were identified as the aliphatic moieties. Summarising, it is most likely that the substance of interest and its hydrolysis products will be subject to metabolism by cytochrome P450 enzymes and subsequent conjugation.
In conclusion, C13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate has a minor potential for bioaccumulation in its non-metabolised form, and will be excreted rapidly after hydrolysis and accompanying / subsequent metabolism.
The present expert statement covers all relevant toxicokinetic parameters to assess the behaviour ofC13-(branched)-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionatein the body, the available information is well-investigated and sufficient to enable one to perform a proper risk assessment. The tonnage-driven data requirement under REACH are fully met and hence, no further information needs to be gathered and further studies can be omitted due to animal welfare.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.